Brief: ISR: No Sign Of Toxicological Reactions For ISR Vaccine Candidate Against SARS-CoV-2
Jan 21 (Reuters) - ISR Immune System Regulation Holding AB
(publ) ISR.ST :
* ISR - RECEIVED REPORT SAYING THERE IS NO SIGN OF
TOXICOLOGICAL
REACTIONS FOR ISR VACCINE CANDIDATE AGAINST SARS-COV-2
Source text for Eikon: ID:nWkr3GPJcF
Further company coverage: ISR.ST
(Gdansk Newsroom)
((Gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on ISR Immune System Regulation Holding AB (publ)
See all newsBrief: ISR Holding Shares To Be Delisted From Nasdaq First North Growth Market
Brief: Nasdaq Stockholm Hands Over Investigation Of ISR Holding To Disciplinary Committee
Brief: ISR Immune System Regulation Holding Receives Notice Of Objection From Nasdaq
Brief: ISR FY 2022 Oper Loss Widens To SEK 205.1 Mln
Brief: ISR Signs Development Agreements With Catalent